TaurelFinance, decoded
Live
Loading market data…
TTaurel

Novartis ends mid-stage trial for Fabhalta in lupus nephritis

Investing.com· Investing.com· Oct 16, 2026 · 5:36 PM
Novartis ends mid-stage trial for Fabhalta in lupus nephritis

This is a summary. Read the complete story at Investing.com below.

Read full article at Investing.com

Related Stories

Saudi Arabia stocks lower at close of trade; Tadawul All Share down 0.84%
stocksabout 9 hours ago

Saudi Arabia stocks lower at close of trade; Tadawul All Share down 0.84%

Investing.com

After a +193% return: A new list of AI-picks for November is NOW LIVE
stocksabout 9 hours ago

After a +193% return: A new list of AI-picks for November is NOW LIVE

Investing.com

China’s BYD extends sales growth streak on strong exports
stocksabout 10 hours ago

China’s BYD extends sales growth streak on strong exports

Investing.com